TPST
Tempest Therapeutics Inc
NASDAQ: TPST · HEALTHCARE · BIOTECHNOLOGY
$1.74
+2.96% today
Updated 2026-04-29
Market cap
$24.67M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-6.33
Dividend yield
—
52W range
$2 – $12
Volume
0.2M
WallStSmart proprietary scores
20
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$11.00
+532.18%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-3.57M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-35.71M | $-29.49M | $-41.84M | $-26.26M | $-4.02M |
| EPS | — | — | — | — | $-6.33 |
| Free cash flow | $-31.63M | $-27.53M | $-33.46M | $-26.82M | $-3.57M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Tempest Therapeutics Inc trades at $1.74. Our Smart Value Score of 20/100 indicates the stock is weak.
Frequently asked questions
What is Tempest Therapeutics Inc's stock price?
Tempest Therapeutics Inc (TPST) trades at $1.74.
Is Tempest Therapeutics Inc overvalued?
Smart Value Score 20/100 (Grade F, Strong Sell).
What is the price target of Tempest Therapeutics Inc (TPST)?
The analyst target price is $11.00, representing +532.2% upside from the current price of $1.74.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-203.60%
Beta-1.89
50D MA$2.06
200D MA$5.69
Shares out0.01B
Float0.01B
Short ratio—
Avg volume0.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—